IFNA2 and hepatocellular carcinoma: On the basis of above-described background, our current study examined the growth inhibitory effects of combination treatment of sorafenib and Pegylated IFN-α2b (PEG-IFN-α2b) on human HCC cell lines in vitro and in vivo.